Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice

International Journal of Urology

Volumn 13, Issue 1, 2006, Pages 47-57

  Abe, Takashige ^a   Tada, Mitsuhiro ^b   Shinohara, Nobuo ^a   Okada, Futoshi ^b   Itoh, Tomoo ^c   Hamada, Jun Ichi ^b   Harabayashi, Toru ^a   Chen, Qinzhong ^a   Moriuchi, Tetsuya ^b   Nonomura, Katsuya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Severe combined immunodeficient (SCID) mice; Urothelial carcinoma; Xenograft

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER TUMOR; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; EVALUATION; FEMALE; GENE MUTATION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IRRADIATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MOUSE STRAIN; NONHUMAN; PELVIS TUMOR; PRIORITY JOURNAL; SCID MOUSE; TUMOR GROWTH; URETER TUMOR; UROGENITAL TRACT TUMOR; XENOGRAFT; YEAST;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSPLANTATION, HETEROLOGOUS; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 33645210895     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01220.x     Document Type: Article

References (22)

1. Johnson JI Decker S Zaharevitz D et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials BrJCancer 2001 84 1424 31
2. Hoffmann J Schmidt-Peter P Hansch W et al. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas ClinCancer Res 1999 5 2198 204
3. Fichtner I Slisow W Gill J et al. Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas EurJCancer 2004 40 298 307
4. Naito S Iwakawa A Tanaka K et al. Heterotransplantation of human urinary bladder cancers in nude mice InvestUrol 1981 18 285 8
5. Hay JH Busuttil A Steel CM Duncan W The growth and histological characteristics of a series of human bladder cancer xenografts RadiotherOncol 1986 7 331 40
6. Kovnat A Buick RN Connolly JG Jewett MA Keresteci AG Tannock IF Comparison of growth of human bladder cancer in tissue culture or as xenografts with clinical and pathological characteristics Cancer Res 1984 44 2530 3
7. Sufrin G McGarry MP Sandberg AA Murphy GP Heterotransplantation of human transitional cell carcinoma in athymic mice JUrol 1979 121 159 61
8. Bankert RB Umemoto T Sugiyama Y Chen FA Repasky E Yokota S Human lung tumors, patients' peripheral blood lymphocytes and tumor infiltrating lymphocytes propagated in scid mice CurrTopMicrobiolImmunol 1989 152 201 10
9. Xu Y Silver DF Yang NP et al. Characterization of human ovarian carcinomas in a SCID mouse model GynecolOncol 1999 72 161 70
10. Angevin E Glukhova L Pavon C et al. Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosis LabInvest 1999 79 879 88
11. McCue PA Gomella LG Veltri RW Marley GM Miller MC Lattime EC Development of secondary structure, growth characteristics and cytogenetic analysis of human transitional cell carcinoma xenografts in scid/scid mice JUrol 1996 155 1128 32
12. Sobin LH Wittekind CH TNM Classification of Malignant Tumors 5th edn Wiley-Liss Inc. New York 1997
13. Mostofi FK Davis CJ Sesterhenn IA Histological Typing of Urinary Bladder Tumors 2nd edn Springer Berlin 1999
14. Cote RJ Esrig D Groshen S Jones PA Skinner DG p53 and treatment of bladder cancer Nature 1997 385 123 5
15. Moonen L Ong F Gallee M et al. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder IntJRadiatOncolBiolPhys 2001 49 1305 10
16. Rodel C Grabenbauer GG Rodel F et al. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation IntJRadiatOncolBiolPhys 2000 46 1213 21
17. Tada M Iggo RD Ishii N et al. Clonality and stability of the p53 gene in human astrocytic tumor cells: quantitative analysis of p53 gene mutations by yeast functional assay IntJCancer 1996 67 447 50
18. Sidransky D Mikkelsen T Schwechheimer K Rosenblum ML Cavanee W Vogelstein B Clonal expansion of p53 mutant cells is associated with brain tumour progression Nature 1992 355 846 7
19. Mosier DE Gulizia RJ Baird SM Wilson DB Transfer of a functional human immune system to mice with severe combined immunodeficiency Nature 1988 335 256 9
20. Bankert RB Egilmez NK Hess SD Human SCID mouse chimeric models for the evaluation of anti-cancer therapies Trends Immunol 2001 22 386 93
21. Chuang CK Liao SK Epstein-Barr virus infection in urothelial transitional cell carcinoma tissues BJU Int 2004 93 495 8
22. Rofstad EK Brustad T Tumour growth delay following single dose irradiation of human melanoma xenografts. Correlations with tumour growth parameters, vascular structure and cellular radiosensitivity BrJCancer 1985 51 201 10